Free Shipping on purchases over €100

Granero Psyllium Bio , 150 gr

Granero Psyllium Bio , 150 gr

Granero Psyllium Bio is a food supplement that helps to improve digestive processes. Its high fibre content stimulates intestinal transit movement to prevent diarrhoea and constipation. It is also rich in prebiotics that protect the stomach walls.

SKU: GR8422584041026
Sold out
Promo FD
10.70
€11.26
Temporarily sold out

Subscribe and we will notify you when it becomes available again.

Pharmaceutical Care

Safe medication sales

Secure shipping

INFO AND TECHNICAL SPECIFICATIONS

Granero Psyllium Bio is a dietary supplement rich in fibre, so it is an alternative that can be used by people with a tendency to suffer from constipation. It encourages good digestion by making it smoother and speeding it up. It stimulates the movement of food bolus to facilitate its expulsion and prevent constipation and diarrhoea.

It contributes to the release of glucose in the intestines, thus helping to lower blood sugar levels. On the other hand, it keeps LDL cholesterol and triglyceride levels under control. As a result, it improves blood pressure, preventing hypertension and heart and artery disease.

Its prebiotic effects enable the intestinal microbiota to be cared for. It helps to eliminate infection-producing bacteria in the gastrointestinal tract. It has satiating properties that help to suppress appetite, making it a great ally in optimising weight-loss diets.

It does not contain eggs or lactose, so it can be consumed by people who are intolerant to these components. It is also suitable for vegans, as its ingredients are totally natural and free of animal additives. It comes in a 150g pouch containing 150g of the nutritional supplement.

Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.